• NICE turns down Darzalex combo for pre-treated multiple myeloma pharmatimes
    July 16, 2018
    According to Janssen, the decision comes despite the consultation papers highlighting the regimen as an innovative treatment combination, which the firm said boosts overall survival and slashes the risk of death by 50 percent.
PharmaSources Customer Service